{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:06:08Z","timestamp":1767625568225,"version":"build-2065373602"},"reference-count":40,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1156446"],"award-info":[{"award-number":["GNT1156446"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Circulating bone marrow-derived endothelial progenitor cells (EPCs) facilitate vascular repair in several organs including the kidney but are progressively diminished in end-stage kidney disease (ESKD) patients, which correlates with cardiovascular outcomes and related mortality. We thus determined if enhancing the tissue-reparative effects of human bone marrow-derived mesenchymal stromal cells (BM-MSCs) with the vasculogenic effects of recombinant human relaxin (RLX) could promote EPC proliferation and function. CD34+ EPCs were isolated from the blood of healthy and ESKD patients, cultured until late EPCs had formed, then stimulated with BM-MSC-derived condition media (CM; 25%), RLX (1 or 10 ng\/mL), or both treatments combined. Whilst RLX alone stimulated EPC proliferation, capillary tube formation and wound healing in vitro, these measures were more rapidly and markedly enhanced by the combined effects of BM-MSC-derived CM and RLX in EPCs derived from both healthy and ESKD patients. These findings have important clinical implications, having identified a novel combination therapy that can restore and enhance EPC number and function in ESKD patients.<\/jats:p>","DOI":"10.3390\/biomedicines10040883","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T21:15:35Z","timestamp":1649798135000},"page":"883","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Novel Approach to Enhance the Regenerative Potential of Circulating Endothelial Progenitor Cells in Patients with End-Stage Kidney Disease"],"prefix":"10.3390","volume":"10","author":[{"given":"Amrilmaen","family":"Badawi","sequence":"first","affiliation":[{"name":"Cardiovascular Disease Program, Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osfred C.","family":"Jefferson","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Program, Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke M.","family":"Huuskes","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Biology and Disease Research, Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Melbourne, VIC 3086, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon D.","family":"Ricardo","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Program, Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Kerr","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Monash Medical Centre, Melbourne, VIC 3168, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0295-4214","authenticated-orcid":false,"given":"Chrishan S.","family":"Samuel","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Program, Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia"},{"name":"Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, VIC 3010, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2535-5134","authenticated-orcid":false,"given":"Padma","family":"Murthi","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Program, Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia"},{"name":"Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC 3010, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: A position statemen from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/1755-1536-5-S1-S14","article-title":"Fibrosis in the kidney: Is a problem shared a problem halved?","volume":"5","author":"Hewitson","year":"2012","journal-title":"Fibrogen. Tissue Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1681\/ASN.2012040390","article-title":"Mechanisms and treatment of CKD","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semnephrol.2015.01.010","article-title":"Renal endothelial injury and microvascular dysfunction in acute kidney injury","volume":"35","author":"Verma","year":"2015","journal-title":"Semin. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semnephrol.2012.02.008","article-title":"Bone marrow cell therapies for endothelial repair and their relevance to kidney disease","volume":"32","author":"Yuen","year":"2012","journal-title":"Semin. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10157-012-0664-9","article-title":"Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease","volume":"17","author":"Chen","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/01.ATV.0000133488.56221.4a","article-title":"Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure","volume":"24","author":"Choi","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1159\/000489745","article-title":"Endothelial progenitor cells and kidney diseases","volume":"43","author":"Ozkok","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"ref_10","first-page":"151","article-title":"Circulating endothelial progenitor cell levels predict cardiovascular events in end-stage renal disease patients on maintenance hemodialysis","volume":"130","author":"Lee","year":"2015","journal-title":"Nephrology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7150\/ijms.14209","article-title":"Endothelial progenitor cells predict long-term mortality in hemodialysis patients","volume":"13","author":"Lu","year":"2016","journal-title":"Int. J. Med. Sci."},{"key":"ref_12","first-page":"131","article-title":"In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury","volume":"34","year":"2013","journal-title":"Clin. Biochem. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1681\/ASN.2017070781","article-title":"Clinical translation of mesenchymal stromal cells therapies in nephrology","volume":"29","author":"Perico","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bph.13529","article-title":"Anti-fibrotic actions of relaxin","volume":"174","author":"Samuel","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1096\/fj.14-254789","article-title":"Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy","volume":"29","author":"Huuskes","year":"2015","journal-title":"FASEB J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/bph.15361","article-title":"Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K\/DOCA\/salt-induced hypertension","volume":"178","author":"Li","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"112256","DOI":"10.1016\/j.biopha.2021.112256","article-title":"Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice","volume":"144","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood-2011-04-346007","article-title":"Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in mice","volume":"119","author":"Segal","year":"2012","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ekir.2017.09.004","article-title":"Endothelial progenitor cells and vascular health in dialysis patients","volume":"3","author":"Huuskes","year":"2018","journal-title":"Kidney Int. Reps."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcell.2019.00045","article-title":"The use of live cell imaging and automated image analysis to assist with determining optimal parameters for angiogenic assay in vitro","volume":"7","author":"Huuskes","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_21","first-page":"585","article-title":"Relaxin in human pregnancy serum measured with a homologous radioimmunoassay","volume":"69","author":"Bell","year":"1987","journal-title":"Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2005080834","article-title":"Endothelial dysfunction contributes to renal function\u2013associated cardiovascular mortality in a population with mild renal insufficiency: The Hoorn study","volume":"17","author":"Stam","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0272-6386(04)01083-2","article-title":"Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis","volume":"44","author":"Herbrig","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0741-5214(00)70080-2","article-title":"Isolation of endothelial cells and their progenitor cells from human peripheral blood","volume":"31","author":"Boyer","year":"2000","journal-title":"J. Vasc. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.0000114236.77009.06","article-title":"Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis","volume":"24","author":"Hur","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_26","first-page":"2C-1","article-title":"Isolation and characterization of endothelial progenitor cells from human blood","volume":"6","author":"Mead","year":"2008","journal-title":"Curr. Prot. Stem. Cell Biology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.yexcr.2007.11.016","article-title":"A comparison of the tube forming potentials of early and late endothelial progenitor cells","volume":"314","author":"Mukai","year":"2008","journal-title":"Exp. Cell Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijcard.2015.03.166","article-title":"Angiogenic potential of early and late outgrowth endothelial progenitor cells is dependent on the time of emergence","volume":"186","author":"Minami","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1182\/blood-2004-04-1396","article-title":"Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood","volume":"104","author":"Ingram","year":"2004","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tice.2011.04.002","article-title":"Implanted bone marrow-derived mesenchymal stem cells fail to metabolically stabilize or recover electromechanical function in infarcted hearts","volume":"43","author":"Eun","year":"2011","journal-title":"Tissue Cell."},{"key":"ref_31","first-page":"281","article-title":"Cell-based therapies for experimental chronic kidney disease: A systematic review and meta-analysis","volume":"8","author":"Papazova","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"F1626","DOI":"10.1152\/ajprenal.00339.2006","article-title":"Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury","volume":"292","author":"Weiss","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.ki.5001521","article-title":"Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3- deficient mice","volume":"70","author":"Ninichuk","year":"2006","journal-title":"Kidney Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3892\/mmr.2015.3409","article-title":"Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis","volume":"12","author":"Shen","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1524-475X.2000.00361.x","article-title":"Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites","volume":"8","author":"Unemori","year":"2000","journal-title":"Wound Repair Regen."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/CS20130105","article-title":"Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice","volume":"125","author":"Bitto","year":"2013","journal-title":"Clin. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.scr.2015.09.007","article-title":"Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease","volume":"15","author":"Royce","year":"2015","journal-title":"Stem Cell Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1681\/ASN.2012121199","article-title":"Human kidney cell reprogramming: Applications for disease modeling and personalized medicine","volume":"24","author":"Ricardo","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"F1132","DOI":"10.1152\/ajprenal.00163.2006","article-title":"End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells","volume":"292","author":"Westerweel","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000441-200304000-00002","article-title":"Cardiovascular mortality in end-stage-renal disease","volume":"325","author":"Collins","year":"2003","journal-title":"Am. J. Med. Sci."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/4\/883\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:52:35Z","timestamp":1760136755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/4\/883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["biomedicines10040883"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10040883","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2022,4,12]]}}}